Pregled bibliografske jedinice broj: 1192872
Is strongyloidiasis currently autochthonous in Croatia? A retrospective study
Is strongyloidiasis currently autochthonous in Croatia? A retrospective study // Transactions of the royal society of tropical medicine and hygiene, 115 (2021), 11; 1298-1303 doi:10.1093/trstmh/trab139 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1192872 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Is strongyloidiasis currently autochthonous in
Croatia? A retrospective study
Autori
Balen Topić, Mirjana ; Marjanović, Ena ; Tomasović, Domagoj ; Sviben, Mario
Izvornik
Transactions of the royal society of tropical medicine and hygiene (0035-9203) 115
(2021), 11;
1298-1303
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Croatia ; autochthonous ; clinical presentation ; diagnostics ; endemicity ; strongyloidiasis
Sažetak
Background: Autochthonous human infections with Strongyloides stercoralis have been well documented in many European regions. By exploring patients' data, we aimed to find elements for its current endemicity in Croatia. Methods: This retrospective descriptive study analysed epidemiological and clinical data of patients treated for strongyloidiasis from January 2010 to May 2019 at a teaching hospital in Zagreb, Croatia. The diagnosis was made by direct methods using light microscopy and/or serology. Results: Among 65 patients with strongyloidiasis, 60% were men, and 78.5% were 50-79 y of age. The sensitivity of the examination of three stool samples after concentration, saline provocation and serology was 26.2, 80.7 and 86.2%, respectively. Clinical presentation included asymptomatic patients with eosinophilia (41.5%), chronic symptomatic infection (33.8%), acute infection (18.5%) and hyperinfection (6.2%). Twenty patients (30.8%) were immunosuppressed ; among four of whom developed hyperinfection, two died. Initially 71.7% of patients were treated with albendazole and 13.3% with ivermectin, with an equal parasitological cure rate (72.2% and 75% ; p=0.09). In 11 patients, acute infection was autochthonous in its origin. Conclusions: Strongyloidiasis is currently endemic in Croatia and immunosuppressed travellers to this region should be advised to take precautions. Patients undergoing immunosuppression and organ donors from Croatia should be screened.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Hrvatski zavod za javno zdravstvo,
Medicinski fakultet, Zagreb,
Klinika za infektivne bolesti "Dr Fran Mihaljević"
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE